CRL Annual EBIT
$717.99 M
+$35.72 M+5.23%
30 December 2023
Summary:
As of January 19, 2025, CRL annual earnings before interest & taxes is $717.99 million, with the most recent change of +$35.72 million (+5.23%) on December 30, 2023. During the last 3 years, it has risen by +$184.45 million (+34.57%). CRL annual EBIT is now at all-time high.CRL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly EBIT
$121.53 M
-$30.90 M-20.27%
28 September 2024
Summary:
As of January 19, 2025, CRL quarterly earnings before interest & taxes is $121.53 million, with the most recent change of -$30.90 million (-20.27%) on September 28, 2024. Over the past year, it has dropped by -$120.72 million (-49.83%). CRL quarterly EBIT is now -56.55% below its all-time high of $279.70 million, reached on December 31, 2022.CRL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM EBIT
$650.21 M
-$25.09 M-3.72%
28 September 2024
Summary:
As of January 19, 2025, CRL TTM earnings before interest & taxes is $650.21 million, with the most recent change of -$25.09 million (-3.72%) on September 28, 2024. Over the past year, it has dropped by -$67.78 million (-9.44%). CRL TTM EBIT is now -13.93% below its all-time high of $755.44 million, reached on September 30, 2023.CRL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.2% | -49.8% | -9.4% |
| 3 y3 years | +34.6% | -49.8% | -9.4% |
| 5 y5 years | +107.8% | -49.8% | -9.4% |
CRL EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.5% | -56.5% | +1.0% | -13.9% | +17.2% |
| 5 y | 5-year | at high | +96.7% | -56.5% | +72.3% | -13.9% | +81.0% |
| alltime | all time | at high | +260.6% | -56.5% | +118.6% | -13.9% | +226.6% |
Charles River Laboratories International EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $121.53 M(-20.3%) | $650.21 M(-3.7%) |
| June 2024 | - | $152.42 M(+13.7%) | $675.30 M(-1.6%) |
| Mar 2024 | - | $134.01 M(-44.7%) | $686.59 M(-4.4%) |
| Dec 2023 | $717.99 M(+5.2%) | $242.25 M(+65.2%) | $717.99 M(-5.0%) |
| Sept 2023 | - | $146.62 M(-10.4%) | $755.44 M(+1.6%) |
| June 2023 | - | $163.71 M(-1.0%) | $743.31 M(+2.2%) |
| Mar 2023 | - | $165.42 M(-40.9%) | $727.42 M(+6.6%) |
| Dec 2022 | $682.28 M(+23.0%) | $279.70 M(+108.0%) | $682.28 M(+18.1%) |
| Sept 2022 | - | $134.48 M(-9.0%) | $577.77 M(-0.9%) |
| June 2022 | - | $147.82 M(+22.9%) | $583.01 M(+0.7%) |
| Mar 2022 | - | $120.28 M(-31.3%) | $578.88 M(+4.4%) |
| Dec 2021 | $554.62 M(+3.9%) | $175.19 M(+25.4%) | $554.62 M(-5.2%) |
| Sept 2021 | - | $139.72 M(-2.8%) | $585.01 M(-2.4%) |
| June 2021 | - | $143.69 M(+49.6%) | $599.42 M(+7.2%) |
| Mar 2021 | - | $96.02 M(-53.3%) | $559.04 M(+4.8%) |
| Dec 2020 | $533.55 M(+46.2%) | $205.57 M(+33.4%) | $533.55 M(+16.5%) |
| Sept 2020 | - | $154.14 M(+49.2%) | $457.90 M(+19.7%) |
| June 2020 | - | $103.30 M(+46.5%) | $382.69 M(+6.5%) |
| Mar 2020 | - | $70.53 M(-45.7%) | $359.21 M(-1.6%) |
| Dec 2019 | $364.97 M(+5.6%) | $129.93 M(+64.6%) | $364.97 M(+11.7%) |
| Sept 2019 | - | $78.93 M(-1.1%) | $326.83 M(-3.4%) |
| June 2019 | - | $79.83 M(+4.7%) | $338.40 M(-2.6%) |
| Mar 2019 | - | $76.28 M(-16.9%) | $347.50 M(+0.6%) |
| Dec 2018 | $345.45 M(+5.7%) | $91.79 M(+1.4%) | $345.45 M(+4.5%) |
| Sept 2018 | - | $90.50 M(+1.8%) | $330.44 M(+3.1%) |
| June 2018 | - | $88.93 M(+19.8%) | $320.55 M(+1.5%) |
| Mar 2018 | - | $74.23 M(-3.3%) | $315.93 M(-3.3%) |
| Dec 2017 | $326.73 M(+30.4%) | $76.78 M(-4.8%) | $326.73 M(+1.7%) |
| Sept 2017 | - | $80.61 M(-4.4%) | $321.19 M(+6.7%) |
| June 2017 | - | $84.32 M(-0.8%) | $300.92 M(+7.5%) |
| Mar 2017 | - | $85.03 M(+19.4%) | $279.90 M(+11.7%) |
| Dec 2016 | $250.63 M(+19.1%) | $71.23 M(+18.1%) | $250.63 M(+7.5%) |
| Sept 2016 | - | $60.34 M(-4.7%) | $233.21 M(+1.4%) |
| June 2016 | - | $63.30 M(+13.5%) | $229.88 M(-0.6%) |
| Mar 2016 | - | $55.76 M(+3.6%) | $231.28 M(+9.9%) |
| Dec 2015 | $210.50 M(+11.1%) | $53.81 M(-5.6%) | $210.50 M(+5.4%) |
| Sept 2015 | - | $57.01 M(-11.9%) | $199.65 M(+5.3%) |
| June 2015 | - | $64.70 M(+85.0%) | $189.52 M(+6.0%) |
| Mar 2015 | - | $34.98 M(-18.6%) | $178.73 M(-5.7%) |
| Dec 2014 | $189.54 M(+19.0%) | $42.97 M(-8.3%) | $189.54 M(+9.9%) |
| Sept 2014 | - | $46.88 M(-13.0%) | $172.51 M(+1.1%) |
| June 2014 | - | $53.91 M(+17.7%) | $170.68 M(+5.9%) |
| Mar 2014 | - | $45.79 M(+76.6%) | $161.16 M(+1.2%) |
| Dec 2013 | $159.30 M(-2.3%) | $25.93 M(-42.4%) | $159.30 M(-5.1%) |
| Sept 2013 | - | $45.05 M(+1.5%) | $167.88 M(+5.1%) |
| June 2013 | - | $44.39 M(+1.1%) | $159.75 M(-2.3%) |
| Mar 2013 | - | $43.93 M(+27.3%) | $163.44 M(+0.2%) |
| Dec 2012 | $163.09 M | $34.51 M(-6.5%) | $163.09 M(-4.7%) |
| Sept 2012 | - | $36.91 M(-23.2%) | $171.19 M(+0.3%) |
| June 2012 | - | $48.08 M(+10.3%) | $170.77 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $43.58 M(+2.3%) | $176.15 M(+0.5%) |
| Dec 2011 | $175.25 M(-158.7%) | $42.62 M(+16.8%) | $175.25 M(-175.9%) |
| Sept 2011 | - | $36.48 M(-31.8%) | -$230.83 M(-12.0%) |
| June 2011 | - | $53.46 M(+25.3%) | -$262.25 M(-8.4%) |
| Mar 2011 | - | $42.68 M(-111.7%) | -$286.21 M(-4.2%) |
| Dec 2010 | -$298.80 M(-272.5%) | -$363.46 M(-7278.7%) | -$298.80 M(-401.9%) |
| Sept 2010 | - | $5.06 M(-82.8%) | $98.98 M(-29.3%) |
| June 2010 | - | $29.51 M(-1.9%) | $139.93 M(-14.2%) |
| Mar 2010 | - | $30.08 M(-12.4%) | $163.06 M(-5.9%) |
| Dec 2009 | $173.24 M(-138.8%) | $34.33 M(-25.4%) | $173.24 M(-133.7%) |
| Sept 2009 | - | $46.01 M(-12.6%) | -$513.70 M(+4.7%) |
| June 2009 | - | $52.64 M(+30.7%) | -$490.64 M(+3.9%) |
| Mar 2009 | - | $40.26 M(-106.2%) | -$472.18 M(+5.6%) |
| Dec 2008 | -$447.00 M(-289.9%) | -$652.61 M(-1044.8%) | -$447.00 M(-268.1%) |
| Sept 2008 | - | $69.08 M(-2.8%) | $265.98 M(+2.1%) |
| June 2008 | - | $71.10 M(+8.6%) | $260.54 M(+5.8%) |
| Mar 2008 | - | $65.44 M(+8.4%) | $246.16 M(+4.6%) |
| Dec 2007 | $235.43 M(+25.1%) | $60.37 M(-5.1%) | $235.43 M(+6.9%) |
| Sept 2007 | - | $63.63 M(+12.2%) | $220.21 M(+5.6%) |
| June 2007 | - | $56.73 M(+3.7%) | $208.50 M(+4.5%) |
| Mar 2007 | - | $54.70 M(+21.1%) | $199.48 M(+233.5%) |
| Dec 2006 | $188.17 M(+1.9%) | $45.15 M(-13.0%) | $59.81 M(+9.5%) |
| Sept 2006 | - | $51.92 M(+8.8%) | $54.61 M(+4.7%) |
| June 2006 | - | $47.70 M(-156.1%) | $52.18 M(-2.5%) |
| Mar 2006 | - | -$84.96 M(-312.7%) | $53.54 M(-70.9%) |
| Dec 2005 | $184.69 M(+16.9%) | $39.95 M(-19.3%) | $183.90 M(+5.2%) |
| Sept 2005 | - | $49.49 M(+0.9%) | $174.84 M(+3.6%) |
| June 2005 | - | $49.06 M(+8.1%) | $168.72 M(+3.0%) |
| Mar 2005 | - | $45.40 M(+47.0%) | $163.87 M(+3.7%) |
| Dec 2004 | $157.99 M(+14.0%) | $30.89 M(-28.8%) | $157.99 M(-2.8%) |
| Sept 2004 | - | $43.37 M(-1.9%) | $162.54 M(+5.9%) |
| June 2004 | - | $44.20 M(+11.9%) | $153.42 M(+6.4%) |
| Mar 2004 | - | $39.52 M(+11.5%) | $144.22 M(+4.1%) |
| Dec 2003 | $138.55 M(+13.3%) | $35.44 M(+3.5%) | $138.55 M(+3.3%) |
| Sept 2003 | - | $34.26 M(-2.1%) | $134.06 M(+1.3%) |
| June 2003 | - | $35.01 M(+3.4%) | $132.33 M(+3.6%) |
| Mar 2003 | - | $33.85 M(+9.3%) | $127.70 M(+4.4%) |
| Dec 2002 | $122.27 M(+35.4%) | $30.95 M(-4.8%) | $122.27 M(+7.5%) |
| Sept 2002 | - | $32.52 M(+7.0%) | $113.72 M(+8.1%) |
| June 2002 | - | $30.38 M(+6.9%) | $105.21 M(+5.9%) |
| Mar 2002 | - | $28.41 M(+26.8%) | $99.32 M(+10.0%) |
| Dec 2001 | $90.28 M(+38.8%) | $22.41 M(-6.7%) | $90.28 M(+10.6%) |
| Sept 2001 | - | $24.01 M(-2.0%) | $81.65 M(+8.2%) |
| June 2001 | - | $24.49 M(+26.4%) | $75.48 M(+9.1%) |
| Mar 2001 | - | $19.37 M(+40.7%) | $69.20 M(+6.4%) |
| Dec 2000 | $65.06 M(+51.4%) | $13.77 M(-22.9%) | $65.06 M(+26.8%) |
| Sept 2000 | - | $17.85 M(-2.0%) | $51.29 M(+53.4%) |
| June 2000 | - | $18.21 M(+19.6%) | $33.45 M(+119.6%) |
| Mar 2000 | - | $15.23 M | $15.23 M |
| Dec 1999 | $42.96 M(+21.6%) | - | - |
| Dec 1998 | $35.33 M | - | - |
FAQ
- What is Charles River Laboratories International annual earnings before interest & taxes?
- What is the all time high annual EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International annual EBIT year-on-year change?
- What is Charles River Laboratories International quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly EBIT year-on-year change?
- What is Charles River Laboratories International TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International TTM EBIT year-on-year change?
What is Charles River Laboratories International annual earnings before interest & taxes?
The current annual EBIT of CRL is $717.99 M
What is the all time high annual EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high annual earnings before interest & taxes is $1.03 B
What is Charles River Laboratories International annual EBIT year-on-year change?
Over the past year, CRL annual earnings before interest & taxes has changed by +$35.72 M (+5.23%)
What is Charles River Laboratories International quarterly earnings before interest & taxes?
The current quarterly EBIT of CRL is $121.53 M
What is the all time high quarterly EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly earnings before interest & taxes is $279.70 M
What is Charles River Laboratories International quarterly EBIT year-on-year change?
Over the past year, CRL quarterly earnings before interest & taxes has changed by -$120.72 M (-49.83%)
What is Charles River Laboratories International TTM earnings before interest & taxes?
The current TTM EBIT of CRL is $650.21 M
What is the all time high TTM EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM earnings before interest & taxes is $755.44 M
What is Charles River Laboratories International TTM EBIT year-on-year change?
Over the past year, CRL TTM earnings before interest & taxes has changed by -$67.78 M (-9.44%)